From: Summary of worldwide pediatric malignancies reported after exposure to etanercept
 | 4-17 years | 18-22 years | ||
---|---|---|---|---|
 | Worldwide | US | Worldwide | US |
Estimated exposure to etanercept (PY) through July 2009 | 49,716 | 33,409 | 33,887 | 22,349 |
All malignancies (rate/100 PY) | 0.020 | 0.015 | 0.024* | 0.013* |
Lymphoma (rate/100 PY) | 0.010 | 0.009 | 0.006* | 0.004* |